Home health is one of the fastest-consolidating sectors in healthcare, driven by the aging population, hospital incentives to reduce readmissions, and Medicare's shift toward value-based purchasing. The CMS moratorium on new Medicare-certified home health agencies in certain states has made existing certifications increasingly valuable as transferable assets. Demographic tailwinds are overwhelming — 10,000 Americans turn 65 daily — and the shift toward hospital-at-home programs is expanding the addressable market.
PE-backed home health platforms like BrightSpring and Amedisys successors, hospital systems building post-acute networks, hospice companies adding referral pipelines, and national franchisors like BrightStar and Home Instead acquiring independents.
Medicare certification and payer mix — a Medicare-certified skilled agency with diversified payer mix trades at 5–6x. Non-medical companion care agencies with Medicaid waiver or private-pay revenue trade at 2.5–3.5x.
Multiple ranges are directional and based on general market experience. Market multiples will vary based on your specific geography and market economics. Your valuation will include comparables that will establish your specific range of value.
Not all home health / home care businesses are created equal in the eyes of a buyer. The spread across the multiple range is enormous. Here is what separates the top from the bottom.
Medicare certification is the single most valuable asset. In moratorium or CON states, the certification is a scarce, transferable regulatory asset worth standalone value. CMS Star ratings directly impact referral volume and managed care contracting — a 4+ star agency commands premium multiples.
Agencies dependent on a single hospital for 40%+ of referrals face concentration risk. Agencies with 10+ active referral sources across hospitals, skilled nursing facilities, and physician practices demonstrate market depth. Direct hospital system relationships — preferred provider status, EMR integration — are particularly valued.
Under the Patient-Driven Groupings Model, reimbursement varies by clinical category, timing, and functional status. Agencies that have optimized their clinical mix generate higher revenue per episode. Buyers model revenue per episode and visits per episode to assess operational efficiency.
Medicare Advantage penetration is growing rapidly. Agencies with established MA contracts at favorable rates are positioned for the industry's reimbursement future. MA contracts are harder to obtain — they require quality data, geographic coverage, and electronic visit verification capabilities.
RNs, PTs, and home health aides are the constrained resource. Agencies with competitive compensation, low turnover, and effective recruitment pipelines are worth materially more. Staffing capacity directly limits census — an agency with referrals it cannot staff is worth less than one filling every referral.
State survey and CMS recertification results are public and scrutinized by buyers. Agencies with clean survey histories and documented compliance programs — QAPI, infection control, OASIS accuracy — reduce regulatory risk. Recent deficiencies cause severe valuation discounts.
Medicare-certified agency acquisitions above $2M EBITDA are predominantly PE-backed or strategic, structured as asset or membership interest purchases with 65–80% cash at close and 15–25% in seller notes or earnouts. The critical mechanic is Medicare provider number transfer to maintain billing continuity.
SBA financing is available for non-medical home care agencies and smaller skilled agencies. Non-medical deals are more straightforward — no Medicare certification transfer required — and are commonly financed with SBA 7(a) plus seller notes.
In CON or moratorium states, the license/certification itself carries standalone value of $500K–$3M+ depending on the market. This value is reflected in the purchase price above the business's cash flow value.
CMS requires specific patient notification procedures during ownership changes. Transition planning must address patient notification, physician order transfers, and uninterrupted care delivery. This regulatory requirement adds complexity but protects both parties when managed properly.
Most home health agency owners we work with are leaving $300K–$1M on the table by not optimizing their clinical mix and PDGM scoring before selling. Proper OASIS documentation and visit utilization efficiency can raise revenue per episode 15–25% without adding patients.
A Medicare-certified agency doing $4M in revenue with $500K adjusted earnings at a 4.5× multiple walks away with $2.25M before taxes. After capital gains and transaction costs, that may be $1.7M. Is that your freedom number? The wealth gap is the distance between your exit proceeds and the life you want after.
You built this agency patient by patient, referral by referral. You know every physician, every discharge planner, every nurse. That dedication built the agency — but it also makes it untransferable. If patients cannot be admitted, scheduled, and cared for without you for 90 days, the readiness gap is open.
Home health agencies typically sell for 2.5–5.0× adjusted earnings. Medicare-certified skilled agencies trade at the top; non-medical companion care at the bottom. In moratorium states, the Medicare certification itself carries standalone value of $500K–$3M+ above cash flow value.
Directly. A 4+ star rating commands premium multiples because it drives referral volume and managed care contracting. A 2-star agency trades at a discount regardless of financial performance. If your rating has room to improve, that is one of the highest-ROI pre-exit investments.
This is the critical question. Staffing capacity limits census capacity. Agencies with competitive compensation, low turnover, and a clinical director the team respects see high retention through transitions. If nurses are loyal to you personally and would leave, that is a readiness gap to close before selling.
With proper planning, billing continuity can be maintained through CMS change-of-information filings. Without it, gaps can last 60–120 days — devastating to cash flow. Experienced buyers structure deals to avoid gaps. This is an area where professional representation protects your deal value.
Three highest-impact moves: (1) Optimize your PDGM clinical mix and OASIS scoring for higher revenue per episode. (2) Secure managed care contracts — MA penetration is growing and agencies without contracts will be left behind. (3) Achieve and maintain a 4+ star CMS rating. These moves routinely add $300K–$800K to a home health exit.
We value your agency using real comps from completed home health transactions — not generic formulas. You get a professional opinion of value with Medicare certification analysis, Star rating impact assessment, payer mix review, and the earnings adjustments specific to home health.
If you have runway, Value Growth coaching helps you optimize PDGM performance, secure managed care contracts, improve your Star rating, and stabilize clinical staffing. Each improvement moves your multiple — and we know which ones home health buyers actually pay for.
When you are ready, we list the agency, screen and qualify buyers (PE platforms, hospital systems, hospice companies, franchise operators), navigate Medicare provider transfer, and sit at the closing table.
The first step costs nothing. Tell us about your business and we will send a market intelligence brief specific to home health in your geography in 24–48 hours. No forms to fight, no pitch attached.